Dementia family-carer coping training,
does it really help with Reduction of depression and anxiety symptoms in family carers of people with dementia?
research showsThe grade is C. START individually randomized 260 carers, 173 to intervention and 87 to treatment as usual. Mean HADS total scores were 12.9 versus 14.9 at four months and 12.4 versus 14.3 at eight months; the adjusted mixed-model difference through eight months was -1.80 points (95% CI -3.29 to -0.31). Differences persisted at 24 months, -2.58 (-4.26 to -0.90), and across 72 months, -2.00 (-3.38 to -0.63). The difference was statistically positive but small when standardized, giving C with 54 points.
ads claimThe effect belongs to the full eight-session bundle, not separately to relaxation, education, or cognitive reframing. A mean HADS difference of 1.8 to 2.6 points cannot be marketed as recovery for most carers.
Useful facts when choosing a product
- START consisted of eight individual sessions over eight to fourteen weeks, delivered by supervised psychology graduates.
- Control received treatment as usual rather than waiting-list control.
- The primary symptom endpoint was carer self-reported HADS.
Chamgap Semantic Classification Code
Candidate index · review held
UNK.eight-session-individual-start-coping-strategy-program.UNK.depression-and-anxiety-symptoms-in-family-carers-of-people-with-dementia.reduce.UNKUnknown > eight-session individual START coping-strategy program > Unknown > depression and anxiety symptoms in family carers of people with dementia > Reduction claim > Unknown
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
At four UK services, 260 family carers were randomized two to one. Supervised psychology graduates delivered eight individual sessions over eight to fourteen weeks. The bundle included dementia and stress education, behavioral management, reframing unhelpful thoughts, acceptance, assertive communication, relaxation, future planning, pleasant activities, and maintenance, with a manual and relaxation audio for home practice. Controls received the services ordinarily available from their clinical teams. Carers completed HADS, while masked researchers collected data at 4, 8, 12, and 24 months. The six-year report followed the same trial and is not independent replication.
Why this is classified as C (54)
A publicly funded individual randomized trial found a self-reported symptom difference lasting six years, but the standardized effect was small and independently unreplicated, giving C with 54 points.
Counterpoint. At eight months, case-level depression was reduced, OR 0.24 (0.07 to 0.76), whereas case-level anxiety remained uncertain, OR 0.30 (0.08 to 1.05). These dichotomized results should be kept separate from the continuous HADS analysis.
Rejudgment record. Cross-check applied — Treatment-as-usual control and self-reported HADS results at 4, 8, 24, and 72 months were separated, and the between-group effect was standardized
| Endpoint | P | Symptom or function itself is the target - including patient reports and performance tests |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E~ | Statistically positive but below the threshold |
Stored derived and displayed grades match; this is not a current recalculation or validity check (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Reduced HADS depression and anxiety symptoms | C | The statistical difference persisted, but its standardized size was about 0.23 to 0.24. |
| Prevention of case-level anxiety | D | The eight-month OR was 0.30 (0.08 to 1.05), including no effect. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Livingston et al. 2013 START | Individually randomized assessor-masked superiority trial | 260 randomized, 173 versus 87; 229 in the short-term primary analysis | Public funding from the UK NIHR Health Technology Assessment programme | HADS total and depression and anxiety subscales at four and eight months | Means 12.9 versus 14.9 at four months and 12.4 versus 14.3 at eight months; adjusted difference -1.80 (-3.29 to -0.31) | Pivotal short-term efficacy evidence |
| Livingston et al. 2014 and 2019 START follow-up | Twenty-four- and seventy-two-month follow-up of the same randomized trial | 209 in the 24-month primary analysis; 222 in the 72-month efficacy analysis | Public UK NIHR HTA funding | HADS total at 24 months and across 72 months | -2.58 points (-4.26 to -0.90) at 24 months; -2.00 (-3.38 to -0.63) across 72 months | Durability evidence, not independent replication |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-08-05).
Final verification and publication gate: Codex · Evidence date: 2026-08-05 · Corrections: none
Cite this verdict
[Chamgap] Dementia family-carer coping training x depression and anxiety — Evidence Grade C·54. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/mood/start-dementia-family-carer-coping-depression-anxiety/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.